Predictors of Anxiety and Depression in Patients with Chronic Viral Hepatitis in Kazakhstan
Polukchi T.V.
2026Dr. Mladen Stojanovic University Hospital
Archives of Psychiatry Research
2026#62Issue 133 - 40 pp.
Aim: Anxiety and depressive disorders are commonly reported comorbidities in patients with chronic viral hepatitis. The burden of living with a chronic illness like hepatitis can significantly impact a person’s mental health. The aim of the study is to explore several key aspects related to anxiety and depression in patients with chronic viral hepatitis in Kazakhstan. Subjects and Methods: A prospective cohort study was conducted involving 233 patients with chronic viral hepatitis. Socio-demographic data were collected, a comprehensive clinical examination was conducted, including assessment of complaints, clinical parameters, and anamnesis data. Laboratory methods were employed, and the severity of anxiety and depressive symptoms was measured using the Hospital anxiety and depression scale (HADS). Results: The analysis of the total scores from HADS in patients with chronic viral hepatitis revealed that 32.6 tion of disease (p < 0.002), aetiology of chronic viral hepatitis (p < 0.030). Conclusion: Integrating the identified predictors into clinical practice allows healthcare providers to improve the early detection and diagnosis of anxiety and depression in patients with chronic viral hepatitis. This proactive approach not only enhances mental health outcomes but also supports overall disease management and patient well-being. © Copyright
Anxiety , depression , fibrosis , hepatitis, chronic , psychiatric status rating scales
Text of the article Перейти на текст статьи
Department of Neurology, psychiatry, rehabilitology and neurosurgery, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
Department of Neurology
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026